Inno Therapeutics

Inno Therapeutics Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Inno Therapeutics, Medical Research Center, B-05-40, Kompleks Perindustrian EmHub, Seksyen 3, Persiaran Surian, Taman Sains, Petaling Jaya.

Inno Therapeutics is an emerging innovative company in drug, vaccine & cellular therapeutic research, development, and manufacturing, focused on advancing translational & transformative healthcare solutions.

🌟 Intern Recognition Ceremony 2025 🌟At Inno Therapeutics, we take pride in nurturing young talents and celebrating their...
23/10/2025

🌟 Intern Recognition Ceremony 2025 🌟

At Inno Therapeutics, we take pride in nurturing young talents and celebrating their growth. During our recent Intern Recognition Ceremony, our interns showcased presentations summarizing their four-month internship journey, highlighting their learnings, projects, and personal growth along the way.

We also celebrated their outstanding achievements with special awards:
🏅 Lim Yu Jik – Emerging Leader Award
🏅 Teishan A/L Puhendhiran – Professional Growth Award
🏅 Tan Teck Zhao – Dedicated Intern Award

Your hard work, enthusiasm, and commitment have left a lasting mark on our team. Congratulations once again and we look forward to seeing where your journey takes you next!

✨ Happy Deepavali ✨This Deepavali, our team came together to honour the Festival of Lights with joy, unity, and meaningf...
20/10/2025

✨ Happy Deepavali ✨

This Deepavali, our team came together to honour the Festival of Lights with joy, unity, and meaningful learning.
A heartfelt thank you to our Indian colleagues who led a wonderful sharing session, giving us deeper insights into the cultural significance, traditions, and values behind Deepavali.

From stories of light triumphing over darkness to the beauty of family rituals and festive treats, it was an inspiring reminder of how culture strengthens connection.

Wishing you a radiant Deepavali filled with light, hope, and new beginnings. May this season of illumination inspire innovation and wellness for all. ✨

— From all of us at Inno Therapeutics

🧬 Organelles As Future Therapeutic AgentsAs science advances, the focus of therapy is shifting from treating the body to...
15/10/2025

🧬 Organelles As Future Therapeutic Agents

As science advances, the focus of therapy is shifting from treating the body to repairing it at the cellular level and now, even within the cell.

Recent studies highlight the potential of organelles such as mitochondria, exosomes, and lysosomes as therapeutic agents themselves. These tiny structures, once thought to only serve housekeeping roles, are now being explored for their roles in cell communication, regeneration, and targeted repair.

The future of therapy may not rely solely on whole cells, but on the functional units that power them which offers a new path toward precision and personalized medicine.

🔬 Visit to AMDI USM: Exploring Mutual Interests for Future CollaborationThe Inno Therapeutics team paid a courtesy visit...
10/10/2025

🔬 Visit to AMDI USM: Exploring Mutual Interests for Future Collaboration

The Inno Therapeutics team paid a courtesy visit to the Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia, to explore potential avenues for collaboration in research and translational development. The discussion was chaired by Prof. Dr. Badrul Hisham Yahaya, Deputy Director of Research and Networking at AMDI USM, and attended by Assoc. Prof. Dr. Rafidah Zainon and Dr. Shuhaidatul Sarmiza Abd Halim.

Both parties engaged in an open exchange to identify mutual areas of interest and assess alignment in capabilities, infrastructure and expertise. With shared objectives in advancing medical innovation, the session served as an important first step towards establishing meaningful research and development partnerships.

🌱 Welcome to the team, Nanthiny!We’re excited to welcome Nanthiny Selvarajan, an intern from Universiti Malaysia Sabah (...
08/10/2025

🌱 Welcome to the team, Nanthiny!

We’re excited to welcome Nanthiny Selvarajan, an intern from Universiti Malaysia Sabah (UMS), who will be joining our team as part of her scientific training and professional development journey.

We look forward to seeing her enthusiasm, ideas, and contributions as she gains hands-on experience in our ongoing research and innovation projects. ✨

Let’s give her a warm welcome and support her as she embarks on this exciting chapter with us!


🔬 Visit to iPharm: Advancing Collaborative Pathways in Therapeutics and Nutraceutical InnovationThe Inno Therapeutics te...
07/10/2025

🔬 Visit to iPharm: Advancing Collaborative Pathways in Therapeutics and Nutraceutical Innovation

The Inno Therapeutics team visited the Institute of Pharmaceuticals and Nutraceuticals (iPharm), a key centre under the National Institutes of Biotechnology Malaysia (NIBM), to explore strategic collaboration in advanced product development. A meeting was conducted with Prof. Madya Dr. Tye Gee Jun, Director of iPharm, where discussions centred on aligning research translation efforts, facility access, and co-development initiatives leveraging iPharm’s analytical platforms, formulation suites, and pilot-scale manufacturing infrastructure.

This engagement was further deepened through a comprehensive tour of iPharm’s core facilities, guided by Mr. Abdul Hadi Ariffin from the Experimental Therapeutics & Toxicology Centre (ETTC) division and Dr. Faisalina Ahmad Fisol from the Animal Research Facility division. Their technical briefings provided valuable insights into iPharm’s preclinical and translational capabilities, setting a strong foundation for pathways in technology transfer, integrated R&D programmes, and scalable innovation under NIBM’s mandate.

Bone marrow–derived mesenchymal stem cells (BM-MSCs) remain one of the most established sources in regenerative medicine...
03/10/2025

Bone marrow–derived mesenchymal stem cells (BM-MSCs) remain one of the most established sources in regenerative medicine, yet their collection is invasive, limited, and often yields low cell numbers.

Menstrual stem cells (MenSCs), on the other hand, are obtained through a non-invasive, renewable process and raise minimal ethical concerns. Despite the cultural stigma surrounding their source, MenSCs are gaining recognition as a promising alternative with broad potential in therapeutic applications.

At Inno Therapeutics, we are committed to advancing awareness and innovation in emerging stem cell sources, bridging science with future solutions. 🌱🩸

Who knew our scientists had killer backhands? 🏓 At Inno, team bonding doesn’t always involve whiteboards. Sometimes it i...
01/10/2025

Who knew our scientists had killer backhands? 🏓 At Inno, team bonding doesn’t always involve whiteboards. Sometimes it involves smashing pickleball shots!

We swapped lab coats for paddles and proved that whether it’s experiments or rallies, agility, teamwork, and quick thinking always win.

Science by day, pickleball pros by… also day. 😎

💥 Meet Your Body’s Tiny Warrior! Say hello to our NK (Natural Killer) cell, the immune system’s frontline hero against c...
28/09/2025

💥 Meet Your Body’s Tiny Warrior!

Say hello to our NK (Natural Killer) cell, the immune system’s frontline hero against cancer! 🧬⚔️

These innate lymphocytes:
Detect stressed or abnormal cells, including virus-infected and cancer cells 👀
Kill targets by delivering perforins and granzymes, sometimes in as little as 20 minutes ⏱️
Play a key role in early immune defense and are now being explored in cancer therapies 💉

💉 Not all vaccines are the same!From traditional approaches to cutting-edge technology, vaccines come in different types...
25/09/2025

💉 Not all vaccines are the same!

From traditional approaches to cutting-edge technology, vaccines come in different types, each designed to protect us in unique ways. 🌍✨

No matter the type, their purpose is the same: to save lives and build healthier communities.

Which type of vaccine surprised you the most?

🌍✨ Inno Therapeutics is honored to be invited by Bioeconomy Corporation to the NRW-Malaysia Biotech Business Forum 2025,...
21/09/2025

🌍✨ Inno Therapeutics is honored to be invited by Bioeconomy Corporation to the NRW-Malaysia Biotech Business Forum 2025, a platform bridging German innovation with Malaysian biotechnology aspirations.

We had the privilege to connect with global leaders shaping the future of life sciences:

🤝 Ulrich Kettling, Head of Contracts & Licensing at Cytiva, sharing insights on advancing biomanufacturing solutions.
🤝 Jan Mach, Managing Director of INOSOLVE Consulting and a GxP expert, discussing strategies for compliance and tech transfer in biotech.

This forum highlights the importance of international partnerships in advancing Malaysia’s biotechnology landscape and strengthening our role in the global bioeconomy.

A heartfelt thank you to Associate Professor Dr. Lim Ghee Seong from the Department of Restorative Dentistry, Faculty of...
19/09/2025

A heartfelt thank you to Associate Professor Dr. Lim Ghee Seong from the Department of Restorative Dentistry, Faculty of Dentistry, Univerisiti Malaya for warmly welcoming us during our recent visitation.

💡🤝 The session provided valuable insights into fostering collaborations and exploring opportunities to advance innovation and research within the dental and healthcare fields.

Address

B-05-40, Kompleks Perindustrian EmHub, Seksyen 3, Persiaran Surian, Taman Sains
Petaling Jaya
47810

Alerts

Be the first to know and let us send you an email when Inno Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Inno Therapeutics:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram